Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
life sciences
migraine
3
×
national
national blog main
national top stories
3
×
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
cancer immunotherapy
fda
fremanezumab
galcanezumab
gene therapy
lasmiditan
medicare
merck
nivolumab
What
companies
3
×
approval
bio
drug
new
roundup
arena’s
arguments
big
biogen’s
biopharmaceutical
bounty
cig
class
comeback
commercialized
competitors
convo
corner
deals
decades
delivered
drugs
earlier
expressing
failures
fda
ipo
life
littered
little
make
meeting
migraine
moderna’s
nash
neuro
news
number
oral
Language
Current search:
migraine
×
companies
×
" national top stories "
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More